| Amanda Lyn Moore, DPT | |
|
777 Maryvale Dr, Cheektowaga, NY 14225-2712 | |
| (716) 631-9515 | |
| Not Available |
| Full Name | Amanda Lyn Moore |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 777 Maryvale Dr, Cheektowaga, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073965620 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amanda Lyn Moore, DPT 777 Maryvale Dr, Cheektowaga, NY 14225-2712 Ph: (716) 631-9515 | Amanda Lyn Moore, DPT 777 Maryvale Dr, Cheektowaga, NY 14225-2712 Ph: (716) 631-9515 |
News Archive
Combination vaccines for young children are commonly used in industrialized nations because they provide protection for multiple diseases in one single injection. However, combination vaccines are prohibitively expensive for developing countries and may not available until several years later, or when market prices are more affordable.
Toxoplasma gondii is a common parasite which causes the development of fatal encephalosis or pneumonia in immunodeficient patients under treatment of AIDS or cancer. Pregnant women who are infected may suffer a miscarriage or the newborn child may suffer from a congenital disease. Currently, a toxoplasma vaccine for humans is not available. Using experimental animals such as mice, basic research for developing an inactivated vaccine is underway.
Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, receives a 2014 Best in KLAS award for Digital X-Ray.
Intuity Medical, Inc., a privately held company developing novel glucose monitoring technologies for diabetes management, announced today it has secured additional funding with the closing of a second tranche of its previously announced Series D Preferred Stock financing, increasing the Series D total to $76 million.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that biosimilars of tumor necrosis factor (TNF)-alpha inhibitors stand to erode $9.6 billion in brand sales (Amgen's Enbrel, Abbott's Humira and Centocor Ortho Biotech/Schering-Plough's Remicade) in the U.S. and Europe (France, Germany, Italy, Spain and U.K.) by 2018. This use of TNF-alpha biosimilars will save healthcare systems in the U.S. and Europe $4 billion.
› Verified 8 days ago
Marie Crawford, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3620 Harlem Rd Ste 2, Cheektowaga, NY 14215 Phone: 716-446-9500 Fax: 716-446-9501 | |
Dr. Michael S Brogan, PT, DPT, PHD Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2355 Union Rd, Cheektowaga, NY 14227 Phone: 716-825-1730 | |
Christin M Fisher, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4635 Union Rd, Cheektowaga, NY 14225 Phone: 716-505-5700 Fax: 716-633-9351 | |
Camillia J Mcklevis, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4635 Union Rd, Cheektowaga, NY 14225 Phone: 716-505-5700 Fax: 716-633-9351 | |
Tyler Whitaker, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 7 Community Dr, Cheektowaga, NY 14225 Phone: 716-505-5651 | |
Samantha E Panfil, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4635 Union Rd, Cheektowaga, NY 14225 Phone: 716-505-5700 Fax: 716-933-9351 |